SavedAdd your journal

Journals / Turkish Journal of Science and Technology / 2023 / Cilt: 18 Sayı: 2

Statistical Evaluation of Treatment Compliance In Children With Attention Deficit Hyperactivity Disorder

Dikkat Eksikliği Hiperaktivite Bozukluğu Olan Çocuklarda Tedavi Uyumunun İstatistiksel Değerlendirilmesi

Duygu MURAT
Uğur TEKİN
Pages
535–542
Publication Date
2023-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We can say that highly educated families who learn that ADHD is a neurodevelopmental disorder and can realize the risks that may arise as a result of being untreated are more careful about drug use.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder.
📊
Key Findings & Data:We found that 39.6% of children with ADHD had high medication adherence accordingly Morisky Medication Adherence Scale.
💡
Conclusion & Impact:We can say that highly educated families who learn that ADHD is a neurodevelopmental disorder and can realize the risks that may arise as a result of being untreated are more careful about drug use.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Dikkat Eksikliği · Hiperaktivite · İlaç Uyumu

Abstract

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder. Pharmacological treatment is the first option in the treatment of ADHD. Long-term treatment is required, as the course of the disease often continues throughout life. Long-term adherence to treatment in ADHD is important in terms of reducing the risk of substance use, accidents, and risk-taking behaviours. Medication adherence is very important for the successful outcome of the treatment. In this study, we aimed to evaluate the factors that may affect treatment adherence in the Turkish sample. We found that 39.6% of children with ADHD had high medication adherence accordingly Morisky Medication Adherence Scale. Medication adherence of boys and girls were similar. When the education level of mothers was compared, the education level of mothers with high medication adherence group was higher than those with poor medication adherence group, and this difference was statistically significant (p=0.013). We can say that highly educated families who learn that ADHD is a neurodevelopmental disorder and can realize the risks that may arise as a result of being untreated are more careful about drug use.

Özet

Dikkat Eksikliği Hiperaktivite Bozukluğu (DEHB) nörogelişimsel bir bozukluktur. DEHB tedavisinde ilk seçenek tedavi farmakolojik tedavidir. Hastalığın seyri çoğu zaman yaşam boyu devam ettiği için uzun süreli tedavi gerekir. DEHB' de tedaviye uzun süreli uyumun olması, madde kullanımı, kaza ve riskli davranışlar riskini azaltabilmektedir. Tedavinin başarılı seyretmesi için ilaç uyumu çok önemlidir. Bu çalışmada tedavi uyumunu etkileyebilecek faktörleri Türkiye örnekleminde değerlendirmeyi amaçladık. Çalışmamızda Morisky İlaç Uyum Ölçeği' ne göre DEHB' li çocukların %39,6'sının ilaç uyumunun yüksek olduğunu saptadık. Kız ve erkek çocukların ilaç uyumu ise benzerdi. Annelerin eğitim durumları karşılaştırıldığında, ilaç uyumu yüksek olan grubun annelerin eğitim düzeyi, ilaç uyumu kötü olan gruba göre daha yüksekti ve bu fark istatistiksel olarak anlamlıydı (p=0,013). Sonuç olarak DEHB' nin nörogelişimsel bir bozukluk olduğunu öğrenen ve tedavi edilmediği takdirde ortaya çıkabilecek riskleri fark edebilen eğitim seviyesi yüksek ailelerin ilaç kullanımı konusunda daha dikkatli olduklarını söyleyebiliriz.

🔖

Cite This Article

MURAT, D., TEKİN, U. (2023). Statistical Evaluation of Treatment Compliance In Children With Attention Deficit Hyperactivity Disorder. Turkish Journal of Science and Technology, Cilt: 18 Sayı: 2, 535–542. https://ajindex.com/articles/959790

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Kemper A.R, Maslow G.R, Hill S, Namdari B, N.M AL, Goode AP, Sanders GD. Attention deficit hyperactivity disorder: diagnosis and treatment in children and adolescents Durham: Europe PMC, 2018.
  2. Ercan E.S, Unsel-Bolat G, Tufan A.E, Karakoc Demirkaya S, Bilac O, Celik G,. & Ünal F. Effect of impairment on the prevalence and comorbidities of attention deficit hyperactivity disorder in a national survey: nation-wide prevalence and comorbidities of ADHD. Journal of Attention Disorders 2022; 26(5): 674-684.
  3. Klein R.G, Mannuzza S, Olazagasti M.A.R, Roizen E, Hutchison J. A, Lashua E. C, & Castellanos F. X. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch. Gen. Psychiatry 2012; 69(12): 1295-1303. Brown T.E. ADHD comorbidities: Handbook for ADHD complications in children and adults. Arlington: American Psychiatric Pub, 2009.
  4. Barnard-Brak L, Roberts B, Valenzuela E. Examining breaks and resistance in medication adherence among adolescents with ADHD as associated with school outcomes. Journal of Attention Disorders 2020; 24(8): 1148-1155.
  5. Kamimura-Nishimura K. I, Brinkman W. B, & Froehlich T. E. Strategies for improving ADHD medication adherence. Current psychiatry 2019; 18(8): 25. Charach A, Fernandez R. Enhancing ADHD medication adherence: challenges and opportunities. Current psychiatry reports 2013; 15: 1-8. Khan M. U, & Aslani P. Exploring factors influencing medication adherence from initiation to discontinuation in parents and adolescents with attention deficit hyperactivity disorder. Clinical pediatrics 2020; 59(3): 285-296.
  6. Raman S. R, Man K. K, Bahmanyar S, Berard A, Bilder S, Boukhris T,. & Wong I. C. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. The Lancet Psychiatry 2018; 5(10): 824-835.
  7. Soutullo C. A, Are F, & Schield-Grant S. Factors associated with adherence to pharmacological treatment of attention deficit hyperactivity disorder (ADHD): preliminary review. Medicina 2023; 83: 27-31. Dopheide J. A. The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD. Am J Manag Care 2009; 15(5 Suppl): S141-50. Mannuzza S, Klein R. G, Bessler A, Malloy P, & LaPadula M. Adult outcome of hyperactive boys: Educational achievement, occupational rank, and psychiatric status. Arch. Gen. Psychiatry 1993; 50(7): 565-576.
  8. Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods A. G, & Arnold